UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment of Leptomeningeal Carcinomatosis in a Patient with Metastatic Pancreatic Cancer: A Case Report and Review of the Literature

Case reports in oncology, 2018-05, Vol.11 (2), p.281-288

2018

Volltextzugriff (PDF)

Gallbladder Carcinoma, the Difficulty of Early Detection: A Case Report

Curēus (Palo Alto, CA), 2016-02

2016

Volltextzugriff (PDF)

Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2014-01, Vol.9 (1), p.121-125

2014

Volltextzugriff (PDF)

Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors

Medical physics (Lancaster), 2003-02, Vol.30 (2), p.199-203

2003

Volltextzugriff (PDF)

Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer

Cancer research (Chicago, Ill.), 2002-07, Vol.62 (14), p.4023

2002

Volltextzugriff (PDF)

Implementation of a virtual tumor board through VA National TeleOncology service

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13571-e13571

2024

Volltextzugriff (PDF)

Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum

Cancer research (Chicago, Ill.), 1985-12, Vol.45 (12), p.6502-6506

1985

Volltextzugriff (PDF)

A limited sampling strategy for cyclophosphamide pharmacokinetics

Cancer research (Chicago, Ill.), 1989-06, Vol.49 (11), p.3129-3133

1989

Volltextzugriff (PDF)

Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion

Cancer research (Chicago, Ill.), 1987-01, Vol.47 (2), p.617-623

1987

Volltextzugriff (PDF)

Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580)

Cancer research (Chicago, Ill.), 1989-06, Vol.49 (12), p.3436

1989

Volltextzugriff (PDF)

Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities

Cancer research (Chicago, Ill.), 1986-03, Vol.46 (3), p.1513-1520

1986

Volltextzugriff (PDF)

Biomarker correlation to clinical response in phase I/II trials of the adjuvant breast cancer vaccine neuvax (nelipepimut-S or E75)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.TPS3126-TPS3126

2013

Volltextzugriff (PDF)

Abstract LB-414: Comparison of in vitro and in vivo immunologic responses in a prospective, randomized, single-blinded phase II trial evaluating the HER-2/ neu peptide vaccines GP2 and AE37 in breast cancer patients

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.LB-414-LB-414

2011

Volltextzugriff (PDF)

Abstract LB-413: Circulating regulatory T cells (CD4+CD25high CD127low) decrease in breast cancer patients after vaccination with a modified HER-2/ neu HLA class II peptide (AE37) vaccine

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.LB-413-LB-413

2011

Volltextzugriff (PDF)

Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer

Archives of otolaryngology--head & neck surgery, 2003-06, Vol.129 (6), p.618

2003

Volltextzugriff (PDF)

The predictive and therapeutic value of thymidine phosphorylase and dihydropyrimidine dehydrogenase in capecitabine (Xeloda)-based chemotherapy for head and neck cancer

The Laryngoscope, 2009-01, Vol.119 (1), p.82-88

2009

Volltextzugriff (PDF)

Plasma pharmacokinetics and urinary excretion of hexamethylene bisacetamide metabolites

Cancer research (Chicago, Ill.), 1987-11, Vol.47 (22), p.6142-6146

1987

Volltextzugriff (PDF)

Response to High Dose (HD) Imatinib Therapy in Relapsed c-kit+ Acute Myeloid Leukemia (AML)

Blood, 2004-11, Vol.104 (11), p.4532-4532

2004

Volltextzugriff (PDF)

943. Prognostic Determinants Associated with Efficacy of Adenoviral p53 Gene Therapy in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck

Molecular therapy, 2006-05, Vol.13 (S1), p.S364

2006

Volltextzugriff (PDF)

Targeted adenovirus-mediated RB94 and cisplatin approach for head and neck cancer

Otolaryngology-head and neck surgery, 2003-08, Vol.129 (2), p.P111-P112

2003

Volltextzugriff (PDF)

The pharmacology of carboplatin

Seminars in oncology, 1989-04, Vol.16 (2 Suppl 5), p.1-6

1989

Volltextzugriff (PDF)

Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancers

Cancer research (Chicago, Ill.), 2002, Vol.62 (14), p.4023-4028

2002

Volltextzugriff (PDF)

11:20 am Targeted Adenovirus-Mediated RB94 and Cisplatin Approach for Head and Neck Cancer

Otolaryngology-head and neck surgery, 2003-08, Vol.129 (2), p.P111-P112

2003

Volltextzugriff (PDF)

In response to Dr. Ochel

International journal of radiation oncology, biology, physics, 2001, Vol.49 (1), p.281-282

2001

Volltextzugriff (PDF)

Treatment of Leptomeningeal Carcinomatosis in a Patient with Metastatic Pancreatic Cancer: A Case Report and Review of the Literature

Case reports in oncology, 2018, Vol.11 (2), p.281-288

2018

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(29)
Berichte
(1)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(14)
Oncology
(11)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Pharmacology. Drug Treatments
(7)
Antineoplastic Agents
(6)
Animals
(5)
Chemotherapy
(5)
Kinetics
(4)
Mice
(4)
Neoplasms - Drug Therapy
(4)
Antineoplastic Agents - Therapeutic Use
(3)
Drug Evaluation
(3)
Male
(3)
Tumors
(3)
Acetamides - Metabolism
(2)
Acetamides - Pharmacokinetics
(2)
Acetamides - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment of Leptomeningeal Carcinomatosis in a Patient with Metastatic Pancreatic Cancer: A Case Report and Review of the Literature

Gallbladder Carcinoma, the Difficulty of Early Detection: A Case Report

Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer

Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors

Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer

Implementation of a virtual tumor board through VA National TeleOncology service

Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum

A limited sampling strategy for cyclophosphamide pharmacokinetics

Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion

Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580)

Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities

Biomarker correlation to clinical response in phase I/II trials of the adjuvant breast cancer vaccine neuvax (nelipepimut-S or E75)

Abstract LB-414: Comparison of in vitro and in vivo immunologic responses in a prospective, randomized, single-blinded phase II trial evaluating the HER-2/ neu peptide vaccines GP2 and AE37 in breast cancer patients

Abstract LB-413: Circulating regulatory T cells (CD4+CD25high CD127low) decrease in breast cancer patients after vaccination with a modified HER-2/ neu HLA class II peptide (AE37) vaccine

Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer

The predictive and therapeutic value of thymidine phosphorylase and dihydropyrimidine dehydrogenase in capecitabine (Xeloda)-based chemotherapy for head and neck cancer

Plasma pharmacokinetics and urinary excretion of hexamethylene bisacetamide metabolites

Response to High Dose (HD) Imatinib Therapy in Relapsed c-kit+ Acute Myeloid Leukemia (AML)

943. Prognostic Determinants Associated with Efficacy of Adenoviral p53 Gene Therapy in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck

Targeted adenovirus-mediated RB94 and cisplatin approach for head and neck cancer

The pharmacology of carboplatin

Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancers

11:20 am Targeted Adenovirus-Mediated RB94 and Cisplatin Approach for Head and Neck Cancer

In response to Dr. Ochel

Treatment of Leptomeningeal Carcinomatosis in a Patient with Metastatic Pancreatic Cancer: A Case Report and Review of the Literature

Aktive Filter

Suchergebnisse filtern